Login | Register

Impact of Cancer and Chemotherapy on Autonomic Nervous System Function and Cardiovascular Reactivity in Young Adults with Cancer: A Feasibility Study

Title:

Impact of Cancer and Chemotherapy on Autonomic Nervous System Function and Cardiovascular Reactivity in Young Adults with Cancer: A Feasibility Study

Adams, Scott (2013) Impact of Cancer and Chemotherapy on Autonomic Nervous System Function and Cardiovascular Reactivity in Young Adults with Cancer: A Feasibility Study. Masters thesis, Concordia University.

[img]
Preview
Text (application/pdf)
Adams_MSc_S2013.pdf - Accepted Version
Available under License Spectrum Terms of Access.
5MB

Abstract

Despite therapeutic advances, cancer patients demonstrate an increased risk of developing disease- and treatment-related cardiovascular (CV) and metabolic morbidity, as compared to their peers. In light of emerging evidence, cancer- and treatment-related damage to the autonomic nervous system (ANS) may play a role in the development of the aforementioned morbidity risks. This assertion needs to be verified. The purpose of this study was to assess the feasibility of conducting concurrent ANS and CV evaluations in adolescent and young adult (AYA) cancer patients undergoing treatment for various cancers by defining the i) methodological pitfalls and best-practice criteria for ANS testing in cancer, and ii) provide initial physiologic evidence of autonomic perturbations in cancer patients using the composite autonomic scoring scale (CASS). Thirteen patients were assessed, pre-treatment (T1) and following 4 cycles of chemotherapy (T2), using CASS and a modified Astrand-Rhyming cycle ergometer protocol, and their results compared to 13 sex and age-match controls. Overall, the average success rate in achieving the targeted feasibility criteria (FC) was 98.5%. Additionally, according to the CASS, there was evidence of ANS impairment at T1 in 5 of 13 patients, which persisted in 4 of 12 patients at T2, compared to 0 of 13 controls at T1 and 1 of 12 controls at T2. Using a 2 x 2 repeated measures ANOVA, treatment led to a significant improvement in patient heart rate (HR) recovery [F=6.188, p=0.027]. Results from this feasibility study suggest the investigation of ANS function in AYA cancer patients undergoing chemotherapy is possible, provided the proper precautions are taken. Furthermore, to the best of our knowledge, this is the first study to report evidence of ANS impairment using CASS and sudomotor dysfunction in this population.

Divisions:Concordia University > Faculty of Arts and Science > Exercise Science
Item Type:Thesis (Masters)
Authors:Adams, Scott
Institution:Concordia University
Degree Name:M.A. Sc.
Program:Exercise Science
Date:2013
Thesis Supervisor(s):Kilgour, Robert and Schondorf, Ronald and Pepin, Veronique
Keywords:Cancer, autonomic nervous system, composite autonomic scoring scale (CASS), young adults
ID Code:977003
Deposited By: SCOTT ADAMS
Deposited On:13 Jun 2013 19:59
Last Modified:18 Jan 2018 17:43
All items in Spectrum are protected by copyright, with all rights reserved. The use of items is governed by Spectrum's terms of access.

Repository Staff Only: item control page

Downloads per month over past year

Back to top Back to top